How biopharma business models are changing in China to meet evolving customer needs;
China's latest policy initiatives meant to support biopharma innovation;
The latest trends impacting patient access to mature and innovative drugs in China;
Updated views on McKinsey's annual China Drug Innovation Index (CDII); and
Key trends shaping the medtech environment in China.
Download the Whitepaper
To download Building Bridges to Innovation 2016, please click the DOWNLOAD link below.
By requesting this White Paper, you hereby Consent to and Agree your personal data will be processed by BioCentury Inc. and McKinsey & Co., the sponsor of the White Paper, in connection with the specific uses set forth below.
Also, you agree that BioCentury may use your information to send you notices about BioCentury publications, products, conferences and services that are of interest to life sciences professionals and investors like yourself, along with notices about conferences and offers from other companies we believe will be of interest to you. Your information is not otherwise shared with any other third parties for marketing purposes.